X4 Pharmaceuticals, Inc Quarterly Cost of Revenue in USD from Q2 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
X4 Pharmaceuticals, Inc quarterly Cost of Revenue history and growth rate from Q2 2023 to Q3 2024.
  • X4 Pharmaceuticals, Inc Cost of Revenue for the quarter ending September 30, 2024 was $227K.
Cost of Revenue, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $227K +$227K Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $268K +$268K Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q3 2023 $0 Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $0 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.